Collaboration to focus on building a leading, US-based biotech dedicated to addressing underserved patients impacted by autoimmune and endocrinology disorders GenSci to receive $70 million ...
Shanghai Scizeng Medical Technology Co Ltd - a subsidiary of Changchun GeneScience Pharmaceutical Co Ltd (GenSci), RTW Investments, a New York-based global full life-cycle investment firm and Yarrow ...
SHANGHAI, Dec. 22, 2023 /PRNewswire/ -- Changchun GeneScience Pharmaceutical ("GenSci"), a subsidiary of Changchun High-Tech Industries (Group), held a groundbreaking ceremony for its new global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results